Assertio Holdings Inc's Customers Performance

Name: Assertio Holdings Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ASRT

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ASRT's Source of Revenues		During the corresponding time, Assertio Holdings Inc saw a revenue deteriorated by -62.5 % year on year, sequentially revenue fell by -26.66 %. While revenue at the Assertio Holdings Inc 's corporate clients • List of ASRT Customers

for the same period Assertio Holdings Inc revnue deteriorated by -62.5 % year on year, sequentially revenue fell by -26.66 %.

• List of ASRT Customers

Assertio Holdings Inc's Business Units


Total product sales net	89.58 %	of total Revenue
ROLVEDON	4.96 %	of total Revenue
INDOCIN products	34.69 %	of total Revenue
Sympazan	25.97 %	of total Revenue
SPRIX	13.79 %	of total Revenue
Other products	10.16 %	of total Revenue
Royalty revenue	4.38 %	of total Revenue
Other revenue	6.04 %	of total Revenue
Product sales net	89.58 %	of total Revenue
CAMBIA Canada	4.03 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Assertio Holdings Inc's Comment on Sales, Marketing and Customers

The company operates in the pharmaceutical market, providing drug products including ROLVEDON, INDOCIN suppositories, and Cambia. It depends on third-party manufacturers and suppliers for these products. The company faces competition from generic and biosimilar versions, which impacts its business. FDA regulations influence the timing of biosimilar applications and approvals for ROLVEDON. The company maintains supply agreements with manufacturers for ROLVEDON and INDOCIN, with recent renegotiations prompted by supplier price increase requests.

Assertio Holdings Inc’s Comment on Sales, Marketing and Customers

ASRT's Stock Performance relative to it's Customers

ASRT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Assertio Holdings inc	151.20	102.16	-35.69	53
Aquestive Therapeutics Inc	506.23	54.09	-78.23	147
Cardinal Health Inc	60,781.80	250,735.00	1,548.00	63,900
Cencora Inc	67,069.12	328,680.02	2,552.33	51,000
Catalent Inc	11,553.36	4,422.00	-413.00	16,900
Mckesson Corporation	122,790.30	410,983.00	5,300.00	51,000
SUBTOTAL	525,401.63	1,989,748.21	17,818.21	365,894

Sources: Assertio Holdings inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, October 17, 2026 5:48 AM
Focus of this report: Assertio Holdings inc’s corporate clients.
For your research, we’ve provided 9 tables on Assertio Holdings inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.